Open AccessPerioperative Management of the Pediatric Patient on Medicinal Marijuana: What Anesthesiologists Should Know
Author(s) -
Kaitlin M Flannery,
Genevieve D'Souza,
Rita Agarwal
Publication year - 2019
Publication title -
anesthesia and analgesia/anesthesia and analgesia
Language(s) - English
Resource type - Journals
eISSN - 1526-7598
pISSN - 0003-2999
DOI - 10.1213/ane.0000000000003956
Subject(s) - medicine , food and drug administration , dosing , perioperative , intensive care medicine , drug , drug administration , medline , pharmacology , anesthesia , law , political science
In 2018, 29 states allow the use of medicinal marijuana. In these states, minors, with parental permission, are granted access. Use has increased in some states, although there remains a paucity of clear evidence regarding usefulness and dosing. There are 2 Food and Drug Administration-approved synthetic derivatives. One purified compound was just approved by the Food and Drug Administration, and another is undergoing Food and Drug Administration review. This article will review the literature regarding the use of each of these compounds in the literature, with particular attention to data in children. The history, known pharmacology, data from nonmedicinal use, current evidence, and anesthetic considerations will be described.